Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 232
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03029533 | Phase 1 Study to Evaluate the Pharmacokinetics and Safety Following SC Administration of DWJ108J in Patients With Prostate Cancer | ||
| NCT04827472 | Study to Evaluate the Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics After Intravenous DWJ1521 Administration in Healthy Adult Volunteers | ||
| NCT05184179 | Observational Study to Evaluate the Therapeutic Effectiveness and Safety of Olomax Tab | ||
| NCT02241850 | Genetic Polymorphisms Affecting Effect of High Intensity Training | ||
| NCT06419816 | Effect of Linking Data Using Smartphone Application, 'Well Check', on Clinical Outcomes in Patients With Type 2 Diabetes Mellitus | ||
| NCT03574285 | A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Feeding Conditions | ||
| NCT01653314 | Megavec 400 mg (Imatinib Mesylate) in Healthy Adult Male Volunteers | ||
| NCT06736587 | Phase 1 Clinical Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP212525 in Healthy Volunteers | ||
| NCT04888728 | To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Volunteers | ||
| NCT03947489 | Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions | ||
| NCT05207176 | Study to Evaluate the Safety and PK Properties of DWP16001 in Healthy Subjects With Various Ethnicities | ||
| NCT06121830 | Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD) | ||
| NCT07267221 | Bioequivalence Study for the Safety and the Pharmacokinetics of DWC202313, DWC202314, and DWJ1622 in Healthy Volunteers Under Fed Condition. | ||
| NCT07013279 | Evaluate the Efficacy and Safety of DWP712 With Moderate to Severe Glabellar Lines | ||
| NCT04393597 | Effects of Food on the Pharmacokinetics of DWJ1458 in Healthy Adults | ||
| NCT02568150 | Evaluation Onset Time of DWP450-004 and Safety in Moderate-severe Glabellar Lines | ||
| NCT03364985 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP16001 After Oral Administration in Healthy Male Volunteers | ||
| NCT05410535 | To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy | ||
| NCT02089399 | Pharmacokinetics and Drug Interaction Study Between Amlodipine,Olmesartan and Rosuvastatin in Healthy Adult Volunteers | ||
| NCT04926623 | Freestyle Libre-based Education on MDI in T2DM (FreEdoM-2) | ||
| NCT02757144 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Male Volunteers | ||
| NCT07260851 | Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1622, DWC202313, and DWC202314 in Healthy Volunteers Under Fasting Conditions | ||
| NCT03487562 | Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of After Administrations of DWP14012 Alone and Combinations of DWP14012, Clarithromycin and Amoxicillin in Healthy Male Subjects | ||
| NCT01764295 | Clinical Study for Patients With Hypertension Associated With Dyslipidemia | ||
| NCT06119945 | Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1568 in Healthy Adult Volunteers | ||
| NCT05607589 | The Safety, Tolerability, PK, and PD of DWP213388 After SAD and MAD Administration in Healthy Adult Subjects | ||
| NCT04159961 | Pharmacokinetics and Safety, Tolerability of DWJ211in Healthy Volunteers | ||
| NCT05376969 | Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin | ||
| NCT06025409 | Evaluate the Efficacy and Safety of DWJ108J | ||
| NCT02346045 | Effect of Renal Denervation in End Staged Renal Disease With Resistant Hypertension | ||
| NCT04185805 | Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers (III) | ||
| NCT06427083 | Registry Study to Determine the Effectiveness and Safety of Weight Loss With Enavogliflozin in Patients With Type 2 Diabetes Mellitus | ||
| NCT04613895 | Treatment Effect According to Timing of Administration of DWP14012 40 mg | ||
| NCT04520022 | Safety and Effectiveness Study of Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cell in Patients With RDEB | ||
| NCT05993247 | Efficacy of Probiotics for NSAID-induced Enteropathy in Arthritis Patients | ||
| NCT07371104 | Bioequivalence Study of DWZ2501 in Patients With Advanced BRCA-mutated High-grade Ovarian Cancer | ||
| NCT03512808 | A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fasting Conditions | ||
| NCT03369990 | DWP450 Treatment in Subjects With Benign Masseteric Hypertrophy | ||
| NCT07144176 | PK and Safety Comparison of DWJ1511 and DWC202501 in Healthy Volunteers | ||
| NCT05845489 | Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION) | ||
| NCT04343547 | Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With DWC202001 and DWC202002 in Healthy Male Adults | ||
| NCT01636401 | Efficacy and Safety of 400 μg Twice Daily of Aclidinium Bromide vs. Placebo When Administered to Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) | ||
| NCT04634500 | The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes. | ||
| NCT04161001 | Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451 | ||
| NCT06437951 | to Evaluate the Safety/Tolerability and Pharmacokinetics, and Pharmacodynamics of DWP14012 Injection | ||
| NCT04749173 | To Assess the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Which is the Treatment of COVID-19 in Healthy Volunteers. | ||
| NCT06671392 | A Phase III Study to Efficacy and Safety of DWC202405/DWC202313 and DWC202314 in Patients With Hypertension | ||
| NCT07619833 | To Evaluate the Efficacy and Safety of Initial Combination Therapy With DWP16001 and DWC202518 Compared to DWP16001 Monotherapy and DWC202518 Monotherapy in Patients With Type 2 Diabetes Mellitus | ||
| NCT03224117 | Clinicial Trial to Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat | ||
| NCT06644404 | Phase 1 Study of Drug-Drug Interactions Between DWP16001, DWC202407, and DWC202408 in Healthy Adults |
